Healthcare Specialty Enzymes Market Set to Grow Exponentially During, 2020 - 2027

11/dic/2020 10:48:46 Grand View Research Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The global healthcare specialty enzymes market size is estimated to reach USD 3.8 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2020 to 2027. Increasing penetration of enzymes in medical applications serves to be a key driving factor for the market. This is also supplemented by extensive research studies being carried out to explore the potential of enzymes in diagnosis as well as therapy. Diagnostic serum enzymes have gained significant attention for the quantification of these offers useful insights regarding abnormal tissue or an organ and help in predicting sites that are susceptible to tissue damage.

Certain products such as aldolase, Creatine Phosphokinase (CPK), gamma-glutamyl transpeptidase, lactic dehydrogenase, lipase, and transaminases are routinely adopted for disease diagnosis. Aldolase is preferably used in the early-stage diagnosis of viral hepatitis as well as advanced prostate cancer. Whereas, CPK has caught the attention of healthcare professionals in terms of both diagnosis and research. CPK tests are performed to diagnose cardiac abnormalities, muscle-associated conditions along with differentiation of post-operative infection from malignant hyperthermia. Thus, the use of enzyme products expanding across various diagnostic applications is set to propel the demand for these products in the healthcare industry.

Enzyme dependent analytical procedures are carried out on a large scale; specificity and potency of these procedures enable amplification as well as detection of a specific target analyte. This has propelled the use of enzyme-based assays in the field of wet chemistry for the quantification of target substances and drugs. Soaring demand for immunodiagnostics, especially Enzyme-linked Immunosorbent Assay (ELISA) boosts the use of specialty enzymes in the amplification of the target signal. Whereas regular use of DNA polymerase for DNA amplification in DNA fingerprinting has increased considerably over the years.

Healthcare Specialty Enzymes Market Report Highlights

·         Carbohydrases accounted for the highest revenue share in 2019 and are anticipated to maintain this trend from 2020 to 2027

·         A major contribution to the revenue generated by this segment in the market is done by amylases and cellulases, as amylases are employed in several biotechnology applications

·         The phosphatase/phytase product segment is set to grow at the fastest pace from 2020 to 2027

·         This is attributed to the rise in use of alkaline phosphatases inclusive of zinc and magnesium ions, which is favored in pharmaceutical applications along with clinical analysis

·         The research and biotechnology end-use segment has generated the highest revenue in 2019, accounting for a share of 64.7%

·         Employment of these products in a diverse range of usages pertaining to DNA modification has been observed in the research and biotechnology studies. In addition, this sector is expected to witness rapid growth with respect to the incorporation of these consumables

·         North America accounted for the highest share of 38.2% in 2019 and is expected to maintain this dominance through 2020 to 2027, attributed to the high penetration of novel diagnostic techniques

·         The Asia Pacific is expected to offer lucrative opportunities for market expansion, attributed to the rising focus on the infectious disease diagnosis

·         A robust network of local manufacturers has significantly contributed to the revenue generated by APAC in the market

Healthcare Specialty Enzymes Market Segmentation

Grand View Research has segmented the global healthcare specialty enzymes market on the basis of product, source, usage, application, technique, end-use, and region:

Healthcare Specialty Enzymes Product Outlook (Revenue, USD Million, 2016 - 2027)

·         Carbohydrases

·         Polymerases and Nucleases

·         Proteases

·         Lipases

·         Phosphatases/Phytases

·         Other Products

Browse Details of Report @

Healthcare Specialty Enzymes Source Outlook (Revenue, USD Million, 2016 - 2027)

·         Micro-organisms

·         Animals

·         Plants

Healthcare Specialty Enzymes Technique Outlook (Revenue, USD Million, 2016 - 2027)

·         Clinical Chemistry

·         Immunodiagnostics/Immunoassays

·         Molecular Diagnostics

·         Hematology

·         Microbiology

Healthcare Specialty Enzymes Usage Outlook (Revenue, USD Million, 2016 - 2027)

·         Research & Biotechnology

·         Diagnosis

Healthcare Specialty Enzymes Application Outlook (Revenue, USD Million, 2016 - 2027)

·         Infectious disease

·         Diabetes

·         Oncology

·         Cardiology

·         Nephrology

·         Autoimmune diseases

blog comments powered by Disqus è un servizio offerto da Factotum Srl